Cargando…
P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431260/ http://dx.doi.org/10.1097/01.HS9.0000970988.41693.dd |
| _version_ | 1785091159265116160 |
|---|---|
| author | Bose, Prithviraj Mohan, Sanjay Oh, Stephen Gotlib, Jason Ritchie, Ellen Shimomura, Taizo Ali, Haris Boyer, Francoise Guglielmelli, Paola Hunter, Anthony M. Lamothe, Betty Cui, Yi Seguy, Francis Mcbride, Amanda Palandri, Francesca Takeuchi, Masahiro Kiladjian, Jean-Jacques |
| author_facet | Bose, Prithviraj Mohan, Sanjay Oh, Stephen Gotlib, Jason Ritchie, Ellen Shimomura, Taizo Ali, Haris Boyer, Francoise Guglielmelli, Paola Hunter, Anthony M. Lamothe, Betty Cui, Yi Seguy, Francis Mcbride, Amanda Palandri, Francesca Takeuchi, Masahiro Kiladjian, Jean-Jacques |
| author_sort | Bose, Prithviraj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431260 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104312602023-08-17 P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS Bose, Prithviraj Mohan, Sanjay Oh, Stephen Gotlib, Jason Ritchie, Ellen Shimomura, Taizo Ali, Haris Boyer, Francoise Guglielmelli, Paola Hunter, Anthony M. Lamothe, Betty Cui, Yi Seguy, Francis Mcbride, Amanda Palandri, Francesca Takeuchi, Masahiro Kiladjian, Jean-Jacques Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431260/ http://dx.doi.org/10.1097/01.HS9.0000970988.41693.dd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bose, Prithviraj Mohan, Sanjay Oh, Stephen Gotlib, Jason Ritchie, Ellen Shimomura, Taizo Ali, Haris Boyer, Francoise Guglielmelli, Paola Hunter, Anthony M. Lamothe, Betty Cui, Yi Seguy, Francis Mcbride, Amanda Palandri, Francesca Takeuchi, Masahiro Kiladjian, Jean-Jacques P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS |
| title | P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS |
| title_full | P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS |
| title_fullStr | P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS |
| title_full_unstemmed | P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS |
| title_short | P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS |
| title_sort | p1022: phase 1/2 study of the activin receptor-like kinase 2 (alk2) inhibitor zilurgisertib (incb000928, limber-104) as monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431260/ http://dx.doi.org/10.1097/01.HS9.0000970988.41693.dd |
| work_keys_str_mv | AT boseprithviraj p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT mohansanjay p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT ohstephen p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT gotlibjason p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT ritchieellen p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT shimomurataizo p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT aliharis p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT boyerfrancoise p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT guglielmellipaola p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT hunteranthonym p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT lamothebetty p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT cuiyi p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT seguyfrancis p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT mcbrideamanda p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT palandrifrancesca p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT takeuchimasahiro p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis AT kiladjianjeanjacques p1022phase12studyoftheactivinreceptorlikekinase2alk2inhibitorzilurgisertibincb000928limber104asmonotherapyorwithruxolitinibinpatientswithanemiaduetomyelofibrosis |